Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | USP30 | Q70CQ3 | 5/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | UCHL1 | P09936 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | SCN4A | P35499 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6675477 | 0.94 | L3MBTL1 (0.47) | L3MBTL1USP30KDM4ELMNAALDH1A1 | |
| SCHEMBL30557537 | 0.83 | L3MBTL1 (0.77) | L3MBTL1USP30KDM4ELMNAALDH1A1 | |
| SCHEMBL25938113 | 0.83 | L3MBTL1 (0.77) | L3MBTL1USP30KDM4ELMNAALDH1A1 | |
| SCHEMBL8333355 | 0.83 | L3MBTL1 (0.77) | L3MBTL1USP30KDM4ELMNAALDH1A1 | |
| SCHEMBL8079479 | 0.82 | PREP (0.55) | L3MBTL1KDM4ELMNAALDH1A1KMT2A | |
| SCHEMBL25938123 | 0.82 | USP30 (0.65) | L3MBTL1USP30KDM4ELMNAALDH1A1 | |
| SCHEMBL25938122 | 0.82 | USP30 (0.65) | L3MBTL1USP30KDM4ELMNAALDH1A1 | |
| SCHEMBL30291360 | 0.81 | GPR119 (0.55) | L3MBTL1USP30LMNAALDH1A1GPR119 | |
| SCHEMBL28975843 | 0.81 | GPR119 (0.55) | L3MBTL1USP30LMNAALDH1A1GPR119 | |
| SCHEMBL8263228 | 0.80 | ACE (0.55) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100273835-A1 | NOVEL COMPOUNDS | PROBIODRUG AG (DE) | 2010-10-28 | — | — | US | disclosed |
| US-20100273835-A1 | NOVEL COMPOUNDS | PROBIODRUG AG (DE) | 2010-10-28 | — | — | US | disclosed |
| WO-2009007415-A2 | NOVEL COMPOUNDS | PROBIODRUG AG (DE) | 2009-01-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100273835-A1 | NOVEL COMPOUNDS | IL6, PREP, PEPD | L3MBTL1 4063/4885USP30 1008/4885KDM4E 1354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.